INTRODUCTION
A decade has now passed since atrial natriuretic peptide (ANP9,-26) was first isolated and characterized from cardiac atria. During this time, other structurally related peptides with natriuretic-diuretic and vasorelaxant activities have been found, including brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP). In the human the main forms are: ahuman (h) ANP (28 residues) (Kangawa and Matsuo, 1984) , hBNP-32 (32 residues) (Sudoh et al., 1988 (Sudoh et al., , 1989 , (22 residues) (Sudoh et al., 1990; Komatsu et al., 1991) with another 53-residue form also in brain and urodilatin (32 residues). Urodilatin was first isolated from human urine and is identical with a-hANP, with four additional residues at the N-terminus (Schulz-Knappe et al., 1988) . All have a disulphide-linked loop of 17 amino acids, the integrity of which is essential for biological activity. ANP is most abundant in cardiac atria, but is also found in several other tissues, including the brain, adrenal gland and testis. BNP is present in brain and heart, the highest concentration being in the atrium, though a greater quantity is present in the ventricles and, in cardiac failure, BNP is the principal natriuretic peptide in plasma (Mukoyama et al., 1990 (Mukoyama et al., , 1991a Hosoda et al., 1991) . CNP is essentially confined to the nervous system, with only small amounts in intestine and kidney (Komatsu et al., 1991; Ueda et al., 1991) . The sequences of BNP from different species vary more widely than is the case for ANP. (E-24.1 1) hydrolyses a-hANP, the initial attack opening the ring by cleavage at the Cys7-Phe8 bond, with more rapidly than a-hANP, as were two C-receptor ligands (peptides with deletions within the ring): C-ANP-23 (rANP4 23 des-Glnt8,Ser'9,Gly20,Leu2t,Gly22) and SC 46542 (hANP,28 desPhe8,Gly9,Alat7,Gln18). Angiotensin-converting enzyme failed to hydrolyse pBNP-32, hBNP-32 or 251I-rat (r) ANP, even after prolonged incubation. Km and kcat values were determined for the hydrolysis of a-hANP, porcine BNP-26, porcine BNP-32 and '251-rANP by E-24. 11. K, values were determined for six peptides, a-hANP, urodilatin, hBNP-32, C-type natriuretic peptide (CNP), SC 46542 and C-type natriuretic peptide (C-ANP4-23), in radiometric assays of E-24.11 with either [1251] insulin B chain or [12511] rANP as substrate. The K, values (2.5-13 ,M) for CNP were the lowest of any of the group, whereas those for hBNP-32 (151-172 uM) were the highest. The physiological significance of these results is discussed, especially in regard to the relative resistance of hBNP-32 to attack and the ability of the C-receptor ligands to compete with natriuretic peptides for hydrolysis by E-24.11. later points of attack at four more sites within the ring and others involving the head and tail sequences (Stephenson and Kenny, 1987a; Vanneste et al., 1988; Kenny and Stephenson, 1988) . pBNP-26 is attacked differently, initially at Sert4-Leu'5 and subsequently at six other bonds, the hydrolysis of the Cys-Phe bond being a relatively late event (Vogt-Schaden et al., 1989; Bourne and Kenny, 1990) . Urodilatin has been reported to be resistant to hydrolysis by dog kidney membranes (which contain E-24. 11) (Gagelmann et al., 1988) , but no information is available on the susceptibility of CNP to hydrolysis by E-24.11 and little on the susceptibility of pBNP-32 and hBNP-32, except for one report indicating hydrolysis at Arg-Leu and Ser-Leu in pBNP, whereas hBNP was cleaved at Pro-Lys, Met-Val (in the N-terminal extension) and at Arg-Ile within the ring. Neither a-hANP or pBNP-26 is attacked by angiotensin converting enzyme, even after prolonged incubation (Stephenson and Kenny, 1987a; Bourne and Kenny, 1990) .
A second mechanism for the clearance of these peptides in vivo has also been proposed, namely receptor-mediated endocytosis. ANP receptors have been identified in many tissues and are of two main types: one is a transmembrane protein capable of binding ligands at the extracytoplasmic domain and generating cyclic GMP at the cytoplasmic domain (Kuno et al., 1986; Chinkers et al., 1989) . This class is therefore biologically active. Another type, the C-receptor, lacks the cyclase domain and is generally considered to be biologically 'silent' (Maack et al., 1987; Fuller et al., 1988 'a' Indicates an amidated C-terminus. Arrows indicate the initial points of attack, these data being from Kenny and Stephenson (1988) , Bourne and Kenny (1990) and the present study.
amino acid substitutions . They outnumber the other types (Scarborough et al., 1986; Fuller et al., 1988) and have been shown to internalize ANP (Johnson et al., 1990; Rathinavelu and Isom, 1991) , thus performing a clearance role. Analogues of ANP, with residues deleted from within the ring, bind selectively with high efficiency to C-receptors. Examples are C-ANP4 23 (C-ligand, des-Gln18,Ser'9,Gly20, Leu21,Gly22-rANP4-23) and SC 46542 (des-Phe8,Gly9,Ala17,Gln'8-hANP128). When C-ANP423 was administered in vivo an increase in plasma ANP levels was observed (Maack et al., 1987 Kenny, 1990 ). The incubations of peptides with the peptidases, the sources and usage of the inhibitors, the h.p.l.c. analyses and identification of the peptide products were identical to those previously described (Bourne and Kenny, 1990 ).
Methods

Determination of kinetic constants
Two approaches were used. In the conventional method, yielding Km and kcat values, initial rates of hydrolysis were determined over a range of substrate concentrations. The times ofincubation, amounts of enzyme and the range of concentrations of the substrates were: a-hANP, 12 min, 75 ng, M; 12 min, 30 ng, 15 min, 75 ng, sM . The extent of hydrolysis of each peptide (mean of all concentrations) was: a-hANP, 26 %; pBNP-26,20 %; pBNP-32, 15 %; however, at the lowest concentrations of the first two, hydrolysis exceeded 25 %.
In the second approach radioiodinated substrates were used and K, values of the peptides determined as competitive inhibitors, rates of hydrolysis being determined by the release of trichloroacetic acid-soluble radioactive fragments. In one series 1251-insulin B chain (0.1 mCi/nmol; concentration range 8-40 #uM) was the substrate (Fulcher and Kenny, 1983) , incubated for 15 min with 40-80 ng of E-24. 11, with or without peptide as inhibitor. In the second series 1251I-rANP128 was the substrate. The assay was set up as follows: 5 ,Ci of radioactive rANP was mixed with unlabelled rANP to give a stock solution, in assay buffer, of 600,uM rANP; assays were set up containing 8-150 ,M rANP, with 5-40 ng of E-24.11 (so as to limit hydrolysis to less than 20%), incubated for 30 min with and without peptide as inhibitor. The unlabelled peptides were present at appropriate concentrations from 25 ,uM to 200 ,M; two concentrations were usually selected for each experiment. The kinetic constants were computed using a program (written by Dr. D. G. Herries of this Department) run on an Amdahl 5860 computer, such that greater weights were assigned to the higher substrate concentrations.
RESULTS
Mode of hydrolysis of pig and human BNP Hydrolysis of pBNP-32
This peptide has a six-residue extension at the N-terminus compared with pBNP-26. The initial cleavage was defined in a time course, part of which is shown in Figure 2 (a), being the h.p.l.c. profile after 25 min incubation of 5 nmol of pBNP-32 with 100 ng of E-24. 11. Peak 1 indicates the initial product; the fraction containing this peptide was collected and the amino acid sequence determined. Two N-terminal residues (Ser, Leu) were detected, and pairs of amino acids were identified in each of the first 12 cycles with single residues in cycles 13-32. The results are therefore consistent with an initial attack within the ring at Ser20-Leu21.
Hydrolysis of hBNP-32
The sequence of this peptide differs in ten residues from that of the pig homologue, including the presence of An 8 nmol portion of hBNP-32 was incubated with 160 ng of E-24.11 at 37°C (vol. 0.16 ml). Yields were calculated from the peak areas (Stephenson and Kenny, 1987b) . Abbreviation: n.d., not determined because more than one peptide present. Peaks are numbered as in Figure 2 (c). Table 1 Peptide products identified after incubation ol E-24.11 for 60 min An 8 nmol portion of hBNP32 was incubated with 160 ng of E-24.11 at 3 Yields were calculated from the peak areas (Stephenson and Kenny, 1987b not determined because more than one peptide present. Peaks are number Peak 3 was not identified. In this Table and Table 2 head region, at Met4-Val5, releasing the N-term (peak 1, Ser-Pro-Lys-Met) from the rest of the pel ring intact (peak 5). Subsequently hydrolysis Arg'7-Ile'8, opening the ring and generating peaks 2 and 4. Some hydrolysis also occurred in the tail, releasing a very small quantity of the C-terminal peptide, Leu-Arg-Arg-His, which was coeluted in peak 1. The products at 24 h represent the final fragments generated by E-24. 11 (Figure 2c ), which were also identified by sequencing and are shown in Table 2 . The bonds shown to be cleaved during this prolonged incubation were: Met4-Val5, Cys10-Phell, Lys14-Met"5, Arg'7-11el8, Gly23-Leu24 and Val28-Leu29.
Hydrolysis of urodilatin
The hydrolysis of urodilatin was monitored over a period of 2 h. The initial product (retention time 10.9 min, compared with 11.5 min for the substrate) was just detectable at 10 min and + reached a maximum at 60 min; it is peak in Figure 2( and urodilatin' are shown in Figure 3b , revealing that Yield:
ANP' accumulated at about twice the rate of urodilatin'. On the (nmol) other hand, the generation of Phe-Arg-Tyr occurred at similar 8_t29) n.d.
rates from the two peptides (Figure 3c Hydrolysis of each peptide was studied under similar conditions (50 ,uM peptide), and the curves are shown in Figure 4 . It is notable that hBNP-32 is hydrolysed relatively slowly (to.5, 2 h, Figure 4a ), compared with the other four peptides, which were iinal fragment rapidly degraded. The to.5 value for at-hANP in this experiment ptide, with the was 8 min (from the logarithmic plots in Figure 4b ), whereas the occurred at other three peptides were hydrolysed even more rapidly, the to. values (relative to a-hANP, = 1.0) were: CNP, 0.6; C-ligand, 0.75 and SC 46542, 0.9.
Kinetic constants for the hydrolysis of natriuretic peptides and C-receptor llgands hANP, urodilatin, C-ANP4-23 and hBNP-32, the last named being a very poor inhibitor (K1 > 150 ,uM) in both assays.
Human BNP-32 was studied in some detail. The most significant finding was that the initial cleavage is outside the ring at Met4-Val5. It remains to be seen whether this has any effect on activity, but given the wide variation in the sequences of the N-terminal peptides of natriuretic peptides, it is likely that inactivation of hBNP-32 requires hydrolysis at bonds within the ring, perhaps at Arg'7-Ile18, which was detected within the first hour. Analysis of the peptides remaining after incubation for 24 h revealed all the points of hydrolysis: Met-Val (in the head) Cys-Phe, Lys-Met, Arg-Ile and Gly-Leu (within the ring) and Val-Leu in the tail. The pattern of attack on bonds within the disulphide linked ring of hBNP differed substantially from that of pBNP-26. Where identical pairs of residues occur, similar bonds were split (Cys-Phe, Arg-Ile, Gly-Leu), but sequence differences elsewhere would seem to account for the reduced number of available sites for hydrolysis in hBNP-32. However, it is highly probable that conformational differences can play an important role in determining the availability of susceptible bonds and also have an effect on overall rates of hydrolysis. These considerations may explain the differences in rates observed for CNP, the C-receptor ligand peptides and urodilatin compared with a-hANP.
Comparing the site of initial attack on a-hANP with the three types of BNP (Figure 1 ) we propose that, where it is encountered, Ser-Leu is the preferred bond (as in pBNP-26 and pBNP-32), but where absent, other sites, such as Cys-Phe (in a-hANP) or Met-Val (in hBNP-32) become the points of initial attack. Not only is hBNP-32 unusual in respect of an initial cleavage point outside the ring, but it also stood out as being hydrolysed at a rate that was an order of magnitude lower than a-hANP or CNP and as being a poor inhibitor of the hydrolysis of labelled insulin B chain or labelled rANP. This poses interesting questions in regard to the role of E-24.11 in metabolizing hBNP compared with a-hANP and CNP. These questions may be especially relevant in pathological states, such as congestive heart failure (Mukoyama et al., 1990) and acute myocardial infarction (Mukoyama et al., 1991b) , where hBNP is the main circulating natriuretic peptide, achieving levels 100-fold higher than in normal subjects.
Effect of ACE on Incubation with 100 ng of purified ACE for 24 h at 37°C in the presence ofinhibitors ofother peptidases (1 ,tM phosphoramidon, 100 ,uM amastatin, 100 ,tM di-isopropyl fluorophosphate) yielded no product peaks on analysis by h.p.l.c. and caused no loss of substrate peak area of pBNP-26 and pBNP-32. When u2aI-rANP was incubated under the same conditions, no radioactive product was detected in the supernatant fraction after precipitation with trichloroacetic acid.
DISCUSSION
Mode of hydrolysis of pBNP-32 and The initial attack on pBNP-32 was at the Ser20-Leu21 bond within the ring, a point of cleavage similar to that observed for pBNP-26. This is hardly surprising, since the sequences within the ring are identical for the two peptides, the only differences being in the N-terminal extension. We did not define the bonds which might have been cleaved later, but it is likely that the pattern of attack would resemble that defined for pBNP-26, namely at Cys-Phe, Arg-Leu, Arg-Ile, Ile-Gly, Ser-Leu and Gly-Leu (within the ring) and at Val-Leu in the tail (Bourne and Kenny, 1990 ).
Hydrolysis of CNP, urodilatin and C-receptor ligands
If hBNP-32 was unusually resistant to hydrolysis by E-24.11, CNP was, by contrast, the most rapidly attacked of the peptides studied. The two synthetic analogues, designed to bind specifically to C-receptors, C-ANP4-23 and SC 46542 were also degraded rapidly, all three peptides being hydrolysed at rates comparable with that of a-hANP. Urodilatin is hydrolysed by E-24.11 at about half the rate of a-hANP, as judged by disappearance of the substrate and by the peak levels of the initial products, but the C-terminal fragments were released at identical rates. These results do not fit with the conclusion of Gagelmann et al. (1988) (based on experiments with dog kidney cortex membranes), namely that the N-terminal extension in the urodilatin sequence " prevents proteolytic attack". However, the time course in their paper shows degradation of urodilatin to have occurred at about 300% of the rate for ANP, slower than our finding, but not implying a totally resistant peptide.
Kinetic constants
The determination of kinetic constants for a substrate that yields multiple products, as is the case with the natriuretic peptides, raises practical and theoretical problems, since there will be several different enzyme-substrate complexes and a Km assessed by observation of the depletion of the intact peptide will be an average value for several reactions. With this approach, pBNP-26 had a lower Km and higher kcat /Km value (specificity constant) than a-hANP or pBNP-32. The specificity constants for all three peptides, ranging from 8 to 25 min--,sM-, can be compared with values of 44 for [Leu] enkephalin, 69 for bradykinin and 159 for substance P (Matsas et al., 1984) . The Km for the hydrolysis of 1251I-rANP was lower, 1 I1sM, and the specificity constant, 44 min-' 7sM-1, was comparable with that for [Leu] enkephalin.
However it is important to bear in mind that the radioactive label is confined to a single residue, Tyr28; hence the radiometric assay depends on the release of the C-terminal tripeptide.
K, values, determined for the peptides as competitive inhibitors in the two radiometric assays of the enzyme, should approximate to Km values for the peptides. Caution is necessary in comparing the values obtained by the two approaches (generally lower when computed as K, values) for the reasons outlined above.
Nonetheless, the ranking orders obtained with the two labelled substrates showed that CNP had the lowest K1 values, followed by SC 46542, whereas hBNP-32 had the highest value, at least an order of magnitude greater than that for CNP. There were some minor differences in the ranking order of the other three peptides, but urodilatin was comparable with a-hANP, and SC 46542 exhibited lower KI values than C-ANP4 23.
The high efficiency with which E-24.11 hydrolysed both Creceptor ligands is important in considering their mechanism of action in vivo or in studies on cells in culture, since their ability to protect endogenous natriuretic peptides will be a function of two actions: occupancy of C-receptors and competition with the peptides for hydrolysis by E-24.11.
ACE was ineffective in vitro in hydrolysing a-hANP (Stephenson and Kenny, 1987a), pBNP-26 and pBNP-32 . This is at odds with the reports that captopril reduced the plasma clearance of 125I-pBNP-26 in rats and that incubation for 1 h of this peptide Iwith 20 ug of a commercial preparation of ACE yielded two radioactive produets, including the C-terminal ArgTyr (Vanneste et al., 1990) . It may be that iodination of the Cterminal residue, or other chemical changes to the peptide, may have rendered it susceptible to attack, but we found no evidence that '251-rANP was hydrolysed, even after prolonged incubation.
Differences in the purity of the enzymes may possibly explain the discrepancy.
